Evaluation should take into consideration a complete blood count, physical examination including gynecological exam, tumor markers (CA‐125, CA 19‐9, AFP), mammography and breast ultrasound, and a thoraco‐abdomino‐pelvic CT scan. Here, AFP is linked to neoplasm.